Further, a number of candidate gene studies have identified associations with increased risk of CAD or myocardial infarction (MI) in individuals with deleterious variants in the estrogen receptor 1 (ESR1 or ERα,) or 2 genes (ESR2 or ERβ) causing dysfunctional or null activity (26–29). Here, ESR2 is linked to myocardial infarction.